Close Menu

Sage Bionetworks’ Stephen Friend lists at Xcomony five technologies that he thinks “will be relegated to museum displays in the next five (OK, maybe 10) years.” That list includes genome-wide association studies, proteomics as an “end approach” to studying disease, and “hunter-gatherer approaches” in which researchers collect clinical and genomic data from a large group, such as the Framingham cohort, to analyze themselves.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.